Alzheimer’s drug cited as Medicare premium jumps by $21.60 By Ricardo Alonso-Zaldivar - Associated Press Shares
‘Still being negotiated’: Progressives’ moves threaten to sink Biden’s framework bill By Valerie Richardson and Haris Alic - The Washington Times Shares
Far-left fears Democratic leaders’ drug-pricing compromise is a ‘sham’ to benefit Big Pharma By Kery Murakami - The Washington Times Shares
In a party of big spenders, Manchin’s $1.5 trillion limit is a lowball bid By Seth McLaughlin - The Washington Times Shares
Maryland residents eligible for free medical equipment By BETHANY PROBST Bethany Probst - Associated Press Shares
COVID-19 pandemic eats into Social Security’s solvency By Stephen Dinan - The Washington Times Shares
Biden tells nursing homes to require worker vaccinations if they want federal money By Tom Howell Jr. - The Washington Times Shares
Pro-Sanders group rebranding into ‘pragmatic progressives’ By Will Weissert - Associated Press Shares
Top Senate Dem sets infrastructure vote, pressures lawmakers By Alan Fram and Lisa Mascaro - Associated Press Shares
Washington takes on Big Pharma: Lower drug prices vs. fewer new cures By Tom Howell Jr. - The Washington Times Shares
Centrist Democrats signal disaster for Nancy Pelosi’s drug plan By Kery Murakami - The Washington Times Shares
Democrats seek narrow path to rein in cost of medicines By Ricardo Alonso-Zaldivar - Associated Press Shares
Liz Weston: 8 ½ birthdays that can affect your finances By LIZ WESTON of NerdWallet - Associated Press Shares
AP-NORC poll: Government should help Americans age at home By EMILY SWANSON and RICARDO ALONSO-ZALDIVAR - Associated Press Shares
Biden pushes Congress to act on agenda, says $1.8 trillion will help families By David Sherfinski and Dave Boyer - The Washington Times Shares
